TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3280092

Group type: EXPERIMENTAL
Intervention: Contact laser cholecystectomy
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional cholecystectomy
Number of subjects: 21
Study: 31990424

Group type: EXPERIMENTAL
Intervention: Vonoprazan 20 mg once daily (V20)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rabeprazole 40 mg twice daily (R40)
Number of subjects: 30
Study: 28536873

Group type: EXPERIMENTAL
Intervention: Caring in Chaos (CiC) BPT model
Number of subjects: 161

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 161
Study: 27037981

Group type: EXPERIMENTAL
Intervention: Transverse technique
Number of subjects: 42

Group type: COMPARATOR
Intervention: Longitudinal technique
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 42
Study: 24709987

Group type: EXPERIMENTAL
Intervention: Attractive proposers (same sex)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Less attractive proposers (same sex)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Male proposers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reasonableness of offers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Willingness to punish
Number of subjects: 0
Study: 23730723

Group type: EXPERIMENTAL
Intervention: Telephone counseling to support physical activity (n = 106)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Contact control (n = 86)
Number of subjects: 192
Study: 20401354

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) alone or in conjunction with conservative treatment
Number of subjects: 6

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT) prior to conservative treatment
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) combined with biofeedback, conservative treatment, and/or self-care
Number of subjects: 6
Study: 17976727

Group type: EXPERIMENTAL
Intervention: Visual acuity assessment
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Quality of life assessment
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Comparison of visual function
Number of subjects: 294
Study: 16293806

Group type: EXPERIMENTAL
Intervention: Volumen (0.1% barium suspension), 1200 mL over 30 minutes
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (water and methylcellulose solution), 1200 mL over 30 minutes
Number of subjects: 60
Study: 14525748

Group type: EXPERIMENTAL
Intervention: Screening for domestic violence using a brief verbal screen by existing ED personnel.
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: ED-based advocacy program.
Number of subjects: 339

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 339
Study: 11027455

Group type: EXPERIMENTAL
Intervention: CVD 908‐htrA(pTETlpp)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: CVD 908‐htrA(pTETnir15)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: CVD 908‐htrA(pTETlpp) and CVD 908‐htrA(pTETnir15)
Number of subjects: 21
Study: 8889711

Group type: EXPERIMENTAL
Intervention: 20% Intralipid emulsions of amphotericin B (ILA)
Number of subjects: 37
Study: 1676779

Group type: EXPERIMENTAL
Intervention: TPGS (d‐alpha‐tocopheryl‐polyethylene‐glycol‐1000 succinate) 25 mg/kg daily
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (non-responders)
Number of subjects: 7
Study: 6352631

Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 59

Group type: COMPARATOR
Intervention: Cefamandole
Number of subjects: 59
Study: 29320594

Group type: EXPERIMENTAL
Intervention: Oxymetazoline hydrochloride cream 1.0% applied once daily for 29 days
Number of subjects: 440

Group type: COMPARATOR
Intervention: Vehicle applied once daily for 29 days
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Oxymetazoline hydrochloride cream 1.0%
Number of subjects: 440

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 440
Study: 27367876

Group type: EXPERIMENTAL
Intervention: Escitalopram (10-20 mg)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study: 24322569

Group type: EXPERIMENTAL
Intervention: Low-dose computed tomography (LDCT)
Number of subjects: 53452

Group type: COMPARATOR
Intervention: Chest radiography (CXR)
Number of subjects: 53452
Study: 22034656

Group type: EXPERIMENTAL
Intervention: Clonidine (150 μg p.o.)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 20837834

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention with standard care
Number of subjects: 151

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 151
Study: 18221408

Group type: EXPERIMENTAL
Intervention: G12 (12 weeks therapy)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: G24 (24 weeks therapy)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: G36 (36 weeks therapy)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: G48 (48 weeks therapy)
Number of subjects: 45
Study: 15739210

Group type: EXPERIMENTAL
Intervention: CHO (carbohydrate-rich drink) 50 kcal/100 ml, 290 mOsm/kg; 800 ml evening before surgery and 400 ml 2 hours before anaesthesia
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo; 800 ml evening before surgery and 400 ml 2 hours before anaesthesia
Number of subjects: 172

Group type: COMPARATOR
Intervention: Fasted group; no intake before surgery
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: CHO (carbohydrate-rich drink)
Number of subjects: 172
Study: 15087294

Group type: EXPERIMENTAL
Intervention: Dexamethasone (1 microM)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Prednisolone (30 mg/day for 7 days)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Theophylline (HDAC enhancer)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Histone acetylation status in AMs
Number of subjects: 34
Study: 11300174

Group type: EXPERIMENTAL
Intervention: School dental screening
Number of subjects: 2321

Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 2321

Group type: COMPARATOR
Intervention: High employed group
Number of subjects: 2321

Group type: COMPARATOR
Intervention: Unemployed group
Number of subjects: 2321
Study: 9309457

Group type: EXPERIMENTAL
Intervention: NSAID (600 mg of Sulindac for one day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy (transdermal system 50 micrograms/d, twice a week, Systen) for 3 months
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 7823005

Group type: EXPERIMENTAL
Intervention: Peptilose-ORS
Number of subjects: 134

Group type: COMPARATOR
Intervention: WHO-ORS
Number of subjects: 134
Study: 2943820

Group type: COMPARATOR
Intervention: Budesonide (Preferid) applied under occlusion for 2, 24, and 48 h
Number of subjects: 19

Group type: COMPARATOR
Intervention: Hydrocortisone, hydrocortisone-butyrate (Locoid), budesonide (Preferid), and klobetasol (Dermovat) applied under occlusion for 1 h
Number of subjects: 19

Group type: COMPARATOR
Intervention: Indomethacin 50 mg i.v. pretreatment
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (vehicle) applied under occlusion
Number of subjects: 19
Study: 29175724

Group type: EXPERIMENTAL
Intervention: Right amygdalohippocampectomy (AHE) patients
Number of subjects: 3

Group type: COMPARATOR
Intervention: Proxies of AHE patients
Number of subjects: 3
Study: 27629576

Group type: EXPERIMENTAL
Intervention: Gluten-poor diet
Number of subjects: 52

Group type: COMPARATOR
Intervention: Gluten-rich diet
Number of subjects: 52

Group type: COMPARATOR
Intervention: Self-reported gluten intake
Number of subjects: 52
Study: 24573971

Group type: EXPERIMENTAL
Intervention: Lidocaine (0.5 mg/kg)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Cisatracurium (0.15 mg/kg)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cisatracurium (0.03 mg/kg)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 200
Study: 22945403

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (280 mg docosahexaenoic acid and 110 mg eicosapentaenoic acid)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Control (olive oil)
Number of subjects: 420
Study: 20164363

Group type: EXPERIMENTAL
Intervention: CHO diet (30% fat, 55% carbohydrate)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: SFA diet (38% fat, 20% SFA)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: MUFA diet (38% fat, 22% MUFA)
Number of subjects: 97

Group type: COMPARATOR
Intervention: All diets
Number of subjects: 97
Study: 18682511

Group type: EXPERIMENTAL
Intervention: Teriparatide after prior treatment with risedronate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Teriparatide after prior treatment with alendronate
Number of subjects: 0
Study: 15885613

Group type: EXPERIMENTAL
Intervention: Observable signs and symptoms assessment by trained police officers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Identification of specific impairing drugs
Number of subjects: 0
Study: 12817157

Group type: EXPERIMENTAL
Intervention: Risperidone (mean daily dose 2 mg, range 0.5-4 mg) added to mood stabilizers
Number of subjects: 108
Study: 10440305

Group type: EXPERIMENTAL
Intervention: Live, attenuated human rotavirus vaccine 89-12 (1x10^5 plaque-forming units)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Live, attenuated human rotavirus vaccine 89-12
Number of subjects: 215
Study: 7825537

Group type: EXPERIMENTAL
Intervention: Soy formula with added selenate (SF+Se, 0.17 mumol Se/L)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Soy formula (SF, 0.028 mumol Se/L)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Soy formula (SF)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Soy formula with added selenate (SF+Se)
Number of subjects: 33
Study: 2141057

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IB, 40 micrograms)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fenoterol (F, 100 micrograms)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combination of ibuprofen and fenoterol (IBF)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (IB)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 638411

Group type: EXPERIMENTAL
Intervention: Dietary restriction and laxatives
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unprepared patients
Number of subjects: 0
Study: 29469601

Group type: EXPERIMENTAL
Intervention: Netarsudil 0.02%
Number of subjects: 11

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 11
Study: 27722092

Group type: EXPERIMENTAL
Intervention: Eliglustat
Number of subjects: 30

Group type: COMPARATOR
Intervention: Imiglucerase
Number of subjects: 30
Study: 24937483

Group type: EXPERIMENTAL
Intervention: Internet interventions
Number of subjects: 5612

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 5612

Group type: COMPARATOR
Intervention: Assessment-only or alcohol information control
Number of subjects: 5612
Study: 22885459

Group type: EXPERIMENTAL
Intervention: Electromagnetic navigation (n = 7)
Number of subjects: 17

Group type: COMPARATOR
Intervention: CT fluoroscopy alone (n = 10)
Number of subjects: 17
Study: 20002637

Group type: EXPERIMENTAL
Intervention: BoNTA (20 U)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227
Study: 19000237

Group type: EXPERIMENTAL
Intervention: After-school program including moderate-to-vigorous physical activity, healthy snacks, homework assistance, and academic enrichment.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual after-school care costs (control condition).
Number of subjects: 0
Study: 15867285

Group type: EXPERIMENTAL
Intervention: Casein protein (CAPM)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Soy protein (SOPM)
Number of subjects: 22
Study: 12766967

Group type: EXPERIMENTAL
Intervention: Active irradiation with linearly polarized 0.6-1.6 microm light (0.92 W, 88.3 J)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo radiation
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Active irradiation
Number of subjects: 18
Study: 10631440

Group type: EXPERIMENTAL
Intervention: TIVA with propofol/remifentanil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Balanced anaesthesia with sevoflurane/fentanyl
Number of subjects: 60
Study: 7575762

Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (0.8 g single daily dose)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (0.4 g two daily doses)
Number of subjects: 1
Study: 2256719

Group type: EXPERIMENTAL
Intervention: Chemoresistance testing at initiation of therapy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Second-look status
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Chemoresistance testing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Stage, residual tumour, second-look status, chemoresistance, ploidy and proliferation
Number of subjects: 50
Study: 6989684

Group type: EXPERIMENTAL
Intervention: tolciclate 1% cream
Number of subjects: 81

Group type: COMPARATOR
Intervention: miconazole 2% cream
Number of subjects: 81
Study: 6333636

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 686

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 686
Study: 31725638

Group type: EXPERIMENTAL
Intervention: Nomogram integrating 8 risk factors
Number of subjects: 1110

Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 1110

Group type: COMPARATOR
Intervention: TNM staging system
Number of subjects: 1110
Study: 30289360

Group type: EXPERIMENTAL
Intervention: Organized recess (instructional tasks and supervision)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Supervised recess (free play with supervision)
Number of subjects: 281
Study: 26536843

Group type: EXPERIMENTAL
Intervention: Early intervention (visit to a physician) for high-risk patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment-as-usual (control group) for high-risk patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-risk patients (not receiving intervention)
Number of subjects: 0
Study: 25284266

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 2

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 2
Study: 22409100

Group type: EXPERIMENTAL
Intervention: Higher feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lower feedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased feedback for fluid ability cues
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decreased feedback for crystallized ability cues
Number of subjects: 0
Study: 19825430

Group type: EXPERIMENTAL
Intervention: Gore-Tex assisted modified Stamm's gastrostomy (GAMSG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional Stamm gastrostomy (CSG)
Number of subjects: 40
Study: 18271282

Group type: EXPERIMENTAL
Intervention: 400 mg/day vitamin E (E400)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 200 mg/day vitamin E (E200)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 250 mg/day vitamin C (C250)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 15673408

Group type: EXPERIMENTAL
Intervention: Pexelizumab bolus (2.0 mg/kg) + placebo infusion
Number of subjects: 914

Group type: EXPERIMENTAL
Intervention: Pexelizumab bolus (2.0 mg/kg) + pexelizumab infusion (0.05 mg/kg/hour for 24 hours)
Number of subjects: 914

Group type: COMPARATOR
Intervention: Placebo bolus + placebo infusion
Number of subjects: 914
Study: 12151925

Group type: EXPERIMENTAL
Intervention: P6 acupoint injections
Number of subjects: 187

Group type: COMPARATOR
Intervention: Droperidol
Number of subjects: 187
Study: 10458212

Group type: EXPERIMENTAL
Intervention: gemcitabine-cisplatin
Number of subjects: 135

Group type: COMPARATOR
Intervention: etoposide-cisplatin
Number of subjects: 135
Study: 9497632

Group type: EXPERIMENTAL
Intervention: Pulsed Nd: YAG laser
Number of subjects: 6

Group type: COMPARATOR
Intervention: Ferric sulphate (13.3%)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Aluminium chloride (25%)
Number of subjects: 6
Study: 2240495

Group type: EXPERIMENTAL
Intervention: Triclofos 70 mg/kg orally 90 minutes before operation
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study: 206923

Group type: EXPERIMENTAL
Intervention: TZM 0.25 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: FZP 15 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Noise alone
Number of subjects: 8

Group type: COMPARATOR
Intervention: MPD alone
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Noise and TZM
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Noise and FZP
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: MPD and TZM
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: MPD and FZP
Number of subjects: 8
Study: 30975195

Group type: EXPERIMENTAL
Intervention: Periodized exercise training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-periodized exercise training (standard guidelines)
Number of subjects: 50
Study: 27329506

Group type: EXPERIMENTAL
Intervention: Daily intermittent hypoxia (IH) combined with body weight-supported treadmill training (BWSTT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous normoxia (Nx) combined with body weight-supported treadmill training (BWSTT)
Number of subjects: 0
Study: 26073353

Group type: EXPERIMENTAL
Intervention: Amfepramone 75 mg daily for 6 months
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 24172292

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (PHRT; n=15)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Endurance exercise training (PHET; n=13)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Time-control group (PHTC; n=15)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Normotensive controls (15 matched participants)
Number of subjects: 43
Study: 22089106

Group type: EXPERIMENTAL
Intervention: Elevated sleep-time blood pressure
Number of subjects: 3344

Group type: COMPARATOR
Intervention: Awake blood pressure measurements
Number of subjects: 3344

Group type: EXPERIMENTAL
Intervention: Asleep mean blood pressure
Number of subjects: 3344
Study: 19251010

Group type: EXPERIMENTAL
Intervention: Fentanyl with midazolam (n = 138)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Meperidine with midazolam (n = 149)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Fentanyl with midazolam (lower doses 2-3.5 mg)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Meperidine with midazolam (lower doses 2-3.5 mg)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Fentanyl with midazolam (higher doses >= 4 mg)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Meperidine with midazolam (higher doses >= 4 mg)
Number of subjects: 287
Study: 17532891

Group type: EXPERIMENTAL
Intervention: Sensory-amplitude electric stimulation (SES) group (n=15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo group (n=15)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both SES and placebo groups
Number of subjects: 30
Study: 15470879

Group type: EXPERIMENTAL
Intervention: Luting material PA (Panavia F/ED Primer)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Luting material VL (Variolink II/Excite)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Luting material DY (Dyract/Prime & Bond NT)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Luting material FU (Fuji Plus/GC Cavity Conditioner)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Composite luting materials PA and VL
Number of subjects: 144

Group type: COMPARATOR
Intervention: RMGIC (resin-modified glass ionomer cement)
Number of subjects: 144
Study: 10919304

Group type: EXPERIMENTAL
Intervention: bupivacaine 15 mg + morphine 5 mg + intraarticular methylprednisolone 40 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: intraarticular saline
Number of subjects: 36
Study: 9010697

Group type: EXPERIMENTAL
Intervention: Candoxatril 25 mg b.i.d.
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Candoxatril 100 mg b.i.d.
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Candoxatril 400 mg b.i.d.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 1490141

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (100 mg/day initially)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vitamin B1 (100 mg/day)
Number of subjects: 50
Study: 2992238

Group type: EXPERIMENTAL
Intervention: Silk sutures
Number of subjects: 1011

Group type: COMPARATOR
Intervention: Polyglycolic acid (PGA) sutures
Number of subjects: 1011
Study: 29690917

Group type: EXPERIMENTAL
Intervention: Substantial weight loss (SWL; 10-15% body weight) using a modified very low energy diet (VLED) program
Number of subjects: 164

Group type: COMPARATOR
Intervention: Modest weight loss (MWL; ≤3% body weight) using a hypocaloric diet
Number of subjects: 164
Study: 28211285

Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) combined with femoral nerve block (FNB) - 150 mL mixture of ropivacaine 2.0 mg/mL + ketorolac 30 mg + adrenaline 10 μg/mL
Number of subjects: 254

Group type: COMPARATOR
Intervention: Control group - FNB only
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) combined with femoral nerve block (FNB)
Number of subjects: 254
Study: 25308884

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT) augmented by Neuromuscular Electrical Stimulation (NMES)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Progressive Resistance Training (PRT)
Number of subjects: 37
Study: 23579078

Group type: EXPERIMENTAL
Intervention: CM-full (n=64)
Number of subjects: 131

Group type: COMPARATOR
Intervention: CM-lite (n=67)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Both CM-full and CM-lite
Number of subjects: 131
Study: 22035223

Group type: EXPERIMENTAL
Intervention: Oxygen persufflation for 2 hours prior to transplantation
Number of subjects: 116

Group type: COMPARATOR
Intervention: Standard procedure (cold storage without further intervention)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Oxygen persufflation
Number of subjects: 116
Study: 18502300

Group type: EXPERIMENTAL
Intervention: succinobucol
Number of subjects: 6144
Study: 16802265

Group type: EXPERIMENTAL
Intervention: Endoscopy performed by nurse endoscopists
Number of subjects: 367

Group type: COMPARATOR
Intervention: Endoscopy performed by doctor endoscopists
Number of subjects: 367